Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 6 Next >
The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts
Tickers IONS
Tags BZI/AAR Benzinga Analyst Ratings
From Benzinga
FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood
Tickers IONS NEWS
Tags Health Care Trading Ideas Movers
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers AMGN CI DOCS HIMS
Tags BZI/AUOA AMGN RGEN
From Benzinga
A Glimpse Into The Expert Outlook On Ionis Pharmaceuticals Through 5 Analysts
Tickers IONS
Tags IONS BZI/AAR Benzinga
From Benzinga
Where Ionis Pharmaceuticals Stands With Analysts
Tickers IONS
Tags IONS Analyst Ratings Benzinga
From Benzinga
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Tickers ADPT ARKG ARKK CDNA
Tags Specialty ETFs Stories That Matter COIN
From Benzinga
Deep Dive Into Ionis Pharmaceuticals Stock: Analyst Perspectives (13 Ratings)
Tickers IONS
Tags Market News BZI/AAR Benzinga
From Benzinga
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Tickers APLD DBX EXTR HPE
Tags Premarket Markets IONS
From Benzinga
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Tickers AMZN ASNS AVO CNET
Tags EGIO Movers AVO
From Benzinga
What 14 Analyst Ratings Have To Say About Ionis Pharmaceuticals
Tickers IONS
Tags Market News Benzinga BZI/AAR
From Benzinga
12 Analysts Have This To Say About Ionis Pharmaceuticals
Tickers IONS
Tags Benzinga BZI/AAR Analyst Ratings
From Benzinga
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
Tickers ALNY AZN BIIB IONS
Tags Movers Trading Ideas AZN
From Benzinga
The Latest Analyst Ratings For Ionis Pharmaceuticals
Tickers IONS
Tags IONS Benzinga BZI/AAR
From Benzinga
Assessing Ionis Pharmaceuticals: Insights From 6 Financial Analysts
Tickers IONS
Tags Analyst Ratings Benzinga BZI/AAR
From Benzinga
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Tickers ALNY ALT ARGX CLOV
Tags Markets IONS PHAR
From Benzinga
Deep Dive Into Ionis Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
Tickers IONS
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Ionis Pharmaceuticals Reveals Late-Stage Donidalorsen Data, Analyst Says Results Show Competitive Hereditary Angioedema Profile
Tickers IONS NEWS
Tags Stories That Matter General Analyst Ratings
From Benzinga
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
Tickers BIIB IONS NEWS
Tags Health Care Briefs Biotech
From Benzinga
Tale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For Another
Tickers BIIB IONS NEWS
Tags Equities IONS General
From Benzinga
The 3 Most Undervalued Pharma Stocks to Buy in May 2024
Tickers BIIB IONS SNY
Tags Market News Stocks to Buy BIIB
From InvestorPlace
The Analyst Landscape: 8 Takes On Ionis Pharmaceuticals
Tickers IONS
Tags Market News Analyst Ratings Benzinga
From Benzinga
IONS Stock Earnings: Ionis Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
Tickers IONS
Tags NASDAQ:IONS IONS Earnings Reports
From InvestorPlace
The Latest Analyst Ratings For Ionis Pharmaceuticals
Tickers IONS
Tags Market News Analyst Ratings Benzinga
From Benzinga
Genetic Medicines Focused-Ionis Pharmaceuticals' Fatty Liver Candidate Lowers Excess Liver Fat, Midstage Study Data Shows
Tickers IONS NEWS
Tags Market News why it's moving News
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Ionis Pharmaceuticals
Tickers IONS
Tags IONS Analyst Ratings Benzinga
From Benzinga
Earnings Scheduled For February 21, 2024
Tickers ACVA ADI AGI AGR
Tags TFPM BRSP MRO
From Benzinga
JP Morgan Maintains Neutral Rating for Ionis Pharmaceuticals: Here's What You Need To Know
Tickers IONS
Tags Analyst Ratings Benzinga Market News
From Benzinga
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
Tickers BIIB IONS NEWS
Tags Alzheimer's disease Health Care pharmaceuticals
From Benzinga
Rare Disease Focused Ionis Pharmaceuticals Gears Up for FDA Submission After Donidalorsen Outperforms Placebo In Swollen Vessels Study
Tickers IONS NEWS
Tags Health Care Trading Ideas Benzinga
From Benzinga
Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 8 Analysts
Tickers IONS
Tags Market News Analyst Ratings Benzinga
From Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.